Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
P02BA01
|
| gptkbp:Bioavailability |
80%
|
| gptkbp:brand |
gptkb:Biltricide
gptkb:Cesol gptkb:Distocide |
| gptkbp:CASNumber |
55268-74-1
|
| gptkbp:chemicalFormula |
C19H24N2O2
|
| gptkbp:discoveredBy |
gptkb:Merck
|
| gptkbp:discoveredIn |
1972
|
| gptkbp:EliminationHalfLife |
0.8-1.5 hours
|
| gptkbp:Excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Praziquantelum
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
increases permeability of cell membranes to calcium ions
|
| gptkbp:meltingPoint |
136-140°C
|
| gptkbp:Metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
B1 (Australia) |
| gptkbp:PubChem_CID |
4891
DB01058 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain dizziness headache |
| gptkbp:UNII |
63HZD5H96B
|
| gptkbp:usedFor |
treatment of schistosomiasis
treatment of tapeworm infections treatment of liver flukes |
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:Praziquantel
gptkb:praziquantel |
| gptkbp:bfsLayer |
7
|